A role of oxidative stress-generated eicosanoid in the progression of arteriosclerosis in type 2 diabetes mellitus model rats

被引:24
作者
Shinomiya, K
Fukunaga, M
Kiyomoto, H
Mizushige, K
Tsuji, T
Noma, T
Ohmori, K
Kohno, M
Senda, S
机构
[1] Kagawa Med Univ, Dept Integrated Med, Kita Ku, Kagawa 7610793, Japan
[2] Kagawa Med Univ, Dept Internal Med 2, Kita Ku, Kagawa 7610793, Japan
关键词
diabetes mellitus; arteriosclerosis; oxidative stress; isoprostanes; insulin-resistance;
D O I
10.1291/hypres.25.91
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Diabetes mellitus (DM) is a well-established risk factor of cardiovascular diseases. We investigated the mechanism of the progression of arteriosclerosis in DM, focusing on the role of oxidative stress and insulin resistance in vivo. Male Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an experimental model of type 2 DM, were assigned to 3 groups, based on supplementation with vitamin E (VE) or troglitazone (TR), a VE-derived agent which improves insulin-resistance. At 36 weeks, plasma and aortic tissue 8-iso-PGF(2alpha) contents, a vascular proliferating eicosanoid produced in vivo by oxidative stress, were measured by EIA. TGF-beta(1) and TGF-beta(1) receptor II were immunohistochemically analyzed. Histopathologically, medial area and the nuclear number of smooth muscle cells of the aorta were measured. The tissue 8-iso-PGF(2alpha) content (pg/g tissue) was significantly decreased by either VE or TR in the aorta (untreated-OLETF, 15,332 +/- 3,254 vs. TR-treated-OLETF, 7,092 +/- 1,992 or VE-treated-OLETF, 5,394 +/- 836, both p < 0.01), but that in plasma decreased by only VE. VE and TR improved the increased the level of the actual medial area and the number of smooth muscle cells. The expression of TGF-β(1) was reduced, but TGF-β(1) receptor II was not. 8-iso-PGF(2α) may play an important role in the progression of arteriosclerosis. Antioxidant treatment may promise significant clinical benefits in the early diabetic stage.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 39 条
[1]   Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial - Veterans Affairs Cooperative Study on gylcemic control and complications in type II diabetes [J].
Abraira, C ;
Colwell, J ;
Nuttall, F ;
Sawin, CT ;
Henderson, W ;
Comstock, JP ;
Emanuele, NV ;
Levin, SR ;
Pacold, I ;
Lee, HS ;
Silbert, CK ;
Cxypoliski, R ;
Vasquez, M ;
Kernan, D ;
Niewoehner, C ;
Backes, M ;
Bradley, M ;
Bradley, M ;
Crow, R ;
Rubino, F ;
Bushnell, D ;
Pfeifer, M ;
Service, FJ ;
Howard, B ;
Chew, E ;
Hoogwerf, B ;
Seigel, D ;
Clark, CM ;
Olefsky, JM ;
Porte, D ;
Sussman, KE ;
Johnson, N ;
Christine, B ;
Tir, K ;
Sather, M ;
Day, P ;
Morgan, N ;
Deykin, D ;
Gold, J ;
Huang, P .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (02) :181-188
[2]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[3]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[4]  
Brownlee M., 1994, ANNU REV MED, V154, P2473
[5]   8-Epi PGF(2 alpha) generation during coronary reperfusion - A potential quantitative marker of oxidant stress in vivo [J].
Delanty, N ;
Reilly, MP ;
Pratico, D ;
Lawson, JA ;
McCarthy, JF ;
Wood, AE ;
Ohnishi, ST ;
Fitzgerald, DJ ;
FitzGerald, GA .
CIRCULATION, 1997, 95 (11) :2492-2499
[6]   EVIDENCE FOR THE EXISTENCE OF F2-ISOPROSTANE RECEPTORS ON RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
FUKUNAGA, M ;
MAKITA, N ;
ROBERTS, LJ ;
MORROW, JD ;
TAKAHASHI, K ;
BADR, KF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (06) :C1619-C1624
[7]   Oxidative stress and diabetic vascular complications [J].
Giugliano, D ;
Ceriello, A ;
Paolisso, G .
DIABETES CARE, 1996, 19 (03) :257-267
[8]   Cross talk between angiotensin II type 1 and type 2 receptors: Cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition [J].
Horiuchi, M ;
Hamai, M ;
Cui, TX ;
Iwai, H ;
Minokoshi, Y .
HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 22 (02) :67-74
[9]   The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data (vol 123, pg 860, 1995) [J].
Jha, P ;
Flather, M ;
Lonn, E ;
Farkouh, M ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (10) :934-934
[10]   Tyrosine-kinase dependent TGF-β and extracellular matrix expression by mechanical stretch in vascular smooth muscle cells [J].
Joki, N ;
Kaname, S ;
Hirakata, M ;
Hori, Y ;
Yamaguchi, T ;
Fujita, T ;
Katoh, T ;
Kurokawa, K .
HYPERTENSION RESEARCH, 2000, 23 (02) :91-99